StimLabs
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1225 Northmeadow Pkwy Ste 104, Roswell, ...Phone Number
(888) 346-9802Website
www.stimlabs.comRevenue
$11.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About StimLabs
StimLabs is a leader in regenerative medicine, specializing in advanced wound care solutions through innovative allografts and extracellular matrix devices. Their comprehensive product portfolio includes both office-based and hospital-based solutions, designed to address a wide range of patient needs. The company is dedicated to enhancing patient care by partnering with physicians and providing superior products and services. StimLabs is committed to advancing the state of regenerative medicine and developing next-generation technologies.Explore more
StimLabs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is StimLabs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if StimLabs has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once StimLabs has new funding data
Product Launch: Get notified when StimLabs launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
StimLabs, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if StimLabs is spiking on competitors!
Earning: See what the market has to say on StimLabs recently announced quarterly report
Click to see if StimLabs had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at StimLabs
Recommended Actions
Find VP level buyers at StimLabs
Find more new buyers
Compare Similar Companies to StimLabs
Compare insights from companies similar to StimLabs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
StimLabs
$11.1M
201-500
Private
<$5M
2015
TD
Thomas DionExecutive Vice President & Chief Commercial Officer
<$5M
51-200
Private
<$5M
1987
AW
Amy WondolkowskiExecutive Managing Director, Medical Practice Surgical Center Medical Spa
Company Profile Activity
Activity Insights
StimLabs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
StimLabs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about StimLabs.
StimLabs financials insights
Gather financial insights about StimLabs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
StimLabs Tech Stack
A closer look at the technologies used by StimLabs
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Medical Research
StimLabs News & Media
StimLabs® Announces FDA 510(k) Clearance for DermaForm™, a Collagen Scaffold Particulate Wound Care Device
ROSWELL, Ga., Feb. 12, 2026 /PRNewswire/ -- StimLabs, a leading regenerative medicine company, announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Geistlich's DermaForm, a Collagen Scaffold Particulate, that is an extracellular matrix wound care...StimLabs® and Geistlich Expand Their Partnership with a New Product Anticipated Q2 2026
ROSWELL, Ga., Jan. 12, 2026 /PRNewswire/ -- StimLabs, a leading regenerative medicine company, announces an expanded partnership with Geistlich, a global leader in the field of regenerative medicine. The partnership began in 2024 with an exclusive national distribution agreement to...StimLabs launches Allacor P for acute and chronic wound care
Allacor P retains key ECM components, including collagen I and hyaluronic acid.Stimlabs® LLC Announces Launch of Allacor P™ - The first FDA 510(k) cleared human umbilical cord particulate device for wound management
ROSWELL, Ga., Jan. 5, 2026 /PRNewswire/ -- StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded an A Code in 2025, allowing StimLabs to launch in...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding StimLabs
Sign Up For FreeTo access detailed company insights
StimLabs is a leader in regenerative medicine, specializing in advanced wound care solutions through innovative allografts and extracellular matrix devices. Their comprehensive product portfolio includes both office-based and hospital-based solutions, designed to address a wide range of patient needs. The company is dedicated to enhancing patient c... Read More
